Cargando…
Clinical efficacy of beta1 selective adrenergic blockers in the treatment of neurocardiogenic syncope – a meta-analysis
BACKGROUND: Beta1 (B(1)) selective blockers have been widely used for the treatment of neurocardiogenic syncope though clinical trials have shown conflicting degrees of efficacy. OBJECTIVE: To study the clinical efficacy of B(1) selective blockers compared to placebo in the treatment of neurocardiog...
Autores principales: | Vallurupalli, Srikanth, Das, Smita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3262373/ https://www.ncbi.nlm.nih.gov/pubmed/22291501 http://dx.doi.org/10.2147/CPAA.S12873 |
Ejemplares similares
-
Physical Training as Non-Pharmacological Treatment of Neurocardiogenic
Syncope
por: Takahagi, Vanessa Cristina Miranda, et al.
Publicado: (2014) -
Treatment of Neurocardiogenic Syncope: From Conservative to Cutting-edge
por: Gampa, Amulya, et al.
Publicado: (2018) -
Myocardial Performance Index in Neurocardiogenic Syncope Patients
por: Yilmaz Coskun, Fatma, et al.
Publicado: (2014) -
Biogenic amine metabolism in juvenile neurocardiogenic syncope with dysautonomia
por: Butler, Ian J, et al.
Publicado: (2014) -
Head-up tilt test in complicated neurocardiogenic syncope in children.
por: Noh, C. I., et al.
Publicado: (1997)